Brian McCauley, MD
Internal Medicine · Providence, RINPI 1538517313
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medtronic at 59.7% of the total. 2025 is the largest year on record at $8,517, more than ten times the $145 reported in 2019. Among internal medicine clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $81.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- W. L. Gore & Associates, Inc.$1K
- Edwards Lifesciences$1K
- Biotronik Inc.$1K
- Abiomed$974
- Abbott$816
- plus $2K from 12 others
What the payments were for
- Travel & lodging$9,73049%
- Food & beverage$9,84650%
- Education$1921%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 96 | $11,792 |
| W. L. Gore & Associates, Inc. | 14 | $1,499 |
| Edwards Lifesciences | 22 | $1,316 |
| Biotronik Inc. | 11 | $1,034 |
| Abiomed | 16 | $974 |
| Abbott | 26 | $816 |
| Inari Medical, Inc. | 5 | $641 |
| Pfizer | 29 | $606 |
| Shockwave Medical, Inc | 2 | $252 |
| Philips North America LLC | 2 | $194 |
| E.r. Squibb & Sons, L.L.C. | 8 | $190 |
| Cardiovascular Systems Inc. | 1 | $163 |
| Teleflex LLC | 2 | $107 |
| Johnson & Johnson | 3 | $57 |
| AstraZeneca | 3 | $52 |
| Scpharmaceuticals Inc. | 2 | $37 |
| Lexicon Pharmaceuticals, Inc. | 1 | $20 |
| Novartis | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$1,688
- GORE CARDIOFORM Septal Occluder$929
- Impella$762
- Orsiro Mission$576
- FLOWTRIEVER CATHETER, S$531
- CT THROMBECTOMY SYSTEM KIT$531
- RESOLUTE ONYX$299
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$249
- Edwards SAPIEN 3 Transcatheter Heart Valve$230
- Diamondback Peripheral$163
- Diamondback Coronary$163
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$158
- CARDIOMEMS$154
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$150
- Passeo-18$150
- PRO-Kinetic Energy$150
- PK Papyrus$150
- ONYX FRONTIER$140
- Resolute$133
- GORE BIO-A Tissue Reinforcement$110
How this compares
$19,768 in reported general payments places this provider in the 95th percentile of 808 internal medicine providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 67 | $56,346 |
| Repatha SureclickEvolocumab | 30 | $21,390 |
| Ezetimibe | 62 | $2,070 |
| Metoprolol Succinate | 70 | $969 |
| ClopidogrelClopidogrel Bisulfate | 90 | $950 |
| Rosuvastatin Calcium | 53 | $930 |
| Atorvastatin Calcium | 59 | $533 |
| Metoprolol Tartrate | 48 | $438 |
| Losartan Potassium | 34 | $343 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 21 | $329 |
| Furosemide | 37 | $202 |
| Carvedilol | 19 | $175 |
| Lisinopril | 22 | $174 |
| Nitroglycerin | 18 | $126 |
| Amlodipine Besylate | 40 | $116 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $606 | $56,34667 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 808 internal medicine providers in Rhode Island.
Other internal medicine in Providence
- Katarzyna Gilek-SeibertProvidence$131K
- Randall InghamProvidence$100K
- Richard RuggieriProvidence$30K
- Gerry OvideProvidence$29K
- Meghan NahassProvidence$19K
- William LangProvidence$15K
- Abdelmoniem MoustafaProvidence$13K
- Khushal ChoudharyProvidence$10K
- Kenneth ChenProvidence$9K
- Prahlad GadhaviProvidence$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.